H-1B sponsorship profile: Corcept Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Corcept Therapeutics, Inc filed 12 Labor Condition Applications covering 12 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (12 certified of 12 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Corcept Therapeutics, Inc’s H-1B petitions range from $137,900 at the low end to $244,837 at the high end, with a petition-weighted average of $196,415. That range reflects the mix of occupations the company sponsors, led by Senior Director, Commercial Analytics (2 petitions at $207,943 avg), followed by Associate Director, Manufacturing and Sr Manager, Regulatory Affairs (Operations). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Corcept Therapeutics, Inc is headquartered in Redwood City, CA under NAICS code 541715, and places H-1B workers across 1 state, most heavily in CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Corcept Therapeutics, Inc ranks. By H-1B petition volume, Corcept Therapeutics, Inc is #14,627 of 119,880 employers nationally and #2,274 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.